- kidney cancer
- novel therapies for melanoma and kidney cancer
Professor James Larkin is a Consultant Medical Oncologist specialising in the treatment of melanoma and cancers of the kidney.
Professor Larkin took a first in Natural Sciences from Cambridge University and undertook clinical training at Oxford University, qualifying in 1996. He underwent general medical training in London and in 2001 won a Medical Research Council Fellowship for a Clinician, carrying out laboratory research at the Institute of Cancer Research leading to a PhD. Specialist training was completed at The Royal Marsden and he was appointed a Consultant in 2008.
His research interests involve trying to understand cancer and its consequences better as well as developing improved treatments, particularly with targeted therapies and immunotherapies.
He is a past NIHR National Specialty Lead for Early Phase Cancer Trials as well past Chair of both the NCRI Renal Cancer Clinical Studies Group and The Royal Marsden/Institute of Cancer Research Committee for Clinical Research. He is currently Chair of the CRUK Clinical Research Monitoring Panel, Vice Chair of the CRUK Clinical Research Committee and Lead of the Uncommon Cancers Theme at the Royal Marsden/ Institute of Cancer Research Biomedical Research Centre. In 2018 he was elected as a Fellow of the Academy of Medical Sciences.
He is a medical advisor to the patient advocacy group Melanoma UK, a trustee of the Kidney Cancer Support Network and serves on the Medical Advisory Board of the International Kidney Cancer Coalition.